Improved outcomes for Kaposi sarcoma using pegylated liposomal doxorubicin | Matthew Coldiron
1 Visualizzazioni
• 06/15/23
0
0
Incorporare
administrator
Iscritti
A study conducted in Mozambique shows pegylated liposomal doxorubicin (PLD) was safe, well-tolerated and effective as first-line treatment for Kaposi’s sarcoma, a common HIV-associated malignancy.
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti